InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Skovronsky Daniel, 董事. Director active across 2 companies, notably Myriad Genetics INC. Aggregated, 20 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €3.8m. History available since 3 June 2021. The latest transaction was filed on 9 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Skovronsky Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
15,547.862 股@ US$1,044.6737.0% 占其流量Common StockSEC:0001741474-26-000004:0
12,684 股0Common StockSEC:0001741474-26-000002:0
179 股0Common StockSEC:0001741474-25-000006:0
1,000 股@ US$634.4052.3% 占其流量Common StockSEC:0000059478-25-000214:0
标准退出：2025年11月10日 (T+90)
49,796 股0Common StockSEC:0001628280-25-029971:0
3,950 股@ US$862.6912.0% 占其流量Common StockSEC:0000059478-25-000039:0
8,989 股0Common StockSEC:0000059478-25-000028:0
111 股0Common StockSEC:0000059478-24-000215:0
15,695 股0Common StockSEC:0001628280-24-027520:0
12,910 股@ US$737.2631.9% 占其流量Common StockSEC:0000059478-24-000052:0
9,941 股0Common StockSEC:0000059478-24-000019:0
17 股0Common StockSEC:0000059478-23-000290:0
249 股0Common StockSEC:0000059478-23-000225:0
15,151 股0Common StockSEC:0001628280-23-020713:0
18,388 股@ US$345.1221.4% 占其流量Common StockSEC:0000059478-23-000063:0
15,675 股0Common StockSEC:0000059478-23-000041:0
17,275 股0Common StockSEC:0001628280-22-016219:0
22,581 股@ US$243.2713.0% 占其流量Common StockSEC:0000059478-22-000052:0
18,735 股0Common StockSEC:0000059478-22-000024:0
12,848 股0Common StockSEC:0000899243-21-022170:0
20 条申报中的 20 条
About Skovronsky Daniel
Skovronsky Daniel is Administrateur and has made 20 filings in total. In the 20 recent filings available, the period runs from 2021-06-04 to 2026-02-11, with 543292 EUR of buys and 3304647 EUR of sells, mainly in ELI LILLY & Co; he is also linked to Myriad Genetics INC.
